ACV AUCTIONS INC-A
ACVANYSE🏆 #1987 by market capEarnings Nov 3US Equity
$10.50▲ $0.00 (+0.00%)
Latest quoteTrack ACVA
Get earnings, price moves & breaking news on Telegram
24h▲ 0.0%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$1.78B
Small Cap
📈Revenue Growth (YoY)
13.3%
Healthy
📊Gross Margin
51.0%
Healthy
💵FCF Margin
8.3%
Moderate
⚖️P/S Ratio
2.2x
Cheap
Otter Score
72
Strong
ACV AUCTIONS INC-A
ACVAAnalyst Ratings
Price
$10.50
Total
18
Raised
2
Lowered
6
Avg PT
$10.17
H / L
$13 / $7
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
CJS Securities | Downgraded | Market Outperform → Market Perform | 2026-09-15 | — | — |
Citigroup | Reiterated | Neutral | 2026-09-14 | $20.00 | +90.50% |
Needham | Downgraded | Buy → Hold | 2026-09-11 | $16.00 | +52.40% |
Barrington Research | Downgraded | Outperform → Underperform | 2026-09-11 | — | — |
Barclays | Downgraded | Equal Weight → Underweight | 2026-08-11 | $8.00 | −23.80% |
Goldman Sachs | Reiterated | Buy | 2026-02-25 | $10.00 | −4.80% |
B. Riley Securities | Reiterated | Buy | 2026-02-24 | — | — |
Jefferies | Downgraded | Buy → Hold | 2025-12-11 | $9.00 | −14.30% |
JP Morgan | Reiterated | Overweight | 2025-11-06 | — | — |
B of A Securities | Downgraded | Buy → Underperform | 2025-11-06 | — | — |
Stephens & Co. | Reiterated | Equal Weight | 2025-08-12 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-08-12 | $21.00 | +100.00% |
Piper Sandler | Upgraded | Neutral → Overweight | 2025-03-20 | $16.00 | +52.40% |
Northcoast Research | Upgraded | Neutral → Buy | 2024-01-10 | — | — |
Guggenheim | Reiterated | Buy | 2023-08-09 | — | — |
Canaccord Genuity | Reiterated | Buy | 2023-05-11 | — | — |
Truist Securities | Reiterated | Buy | 2022-05-12 | — | — |
Raymond James | Reiterated | Market Perform → Perform | 2021-04-19 | — | — |
Institution
CJS Securities
Downgraded · Market Outperform → Market Perform · 2026-09-15
—
—
Citigroup
Reiterated · Neutral · 2026-09-14
$20.00
+90.50%
Needham
Downgraded · Buy → Hold · 2026-09-11
$16.00
+52.40%
Barrington Research
Downgraded · Outperform → Underperform · 2026-09-11
—
—
Barclays
Downgraded · Equal Weight → Underweight · 2026-08-11
$8.00
−23.80%
Goldman Sachs
Reiterated · Buy · 2026-02-25
$10.00
−4.80%
B. Riley Securities
Reiterated · Buy · 2026-02-24
—
—
Jefferies
Downgraded · Buy → Hold · 2025-12-11
$9.00
−14.30%
JP Morgan
Reiterated · Overweight · 2025-11-06
—
—
B of A Securities
Downgraded · Buy → Underperform · 2025-11-06
—
—
Stephens & Co.
Reiterated · Equal Weight · 2025-08-12
—
—
JMP Securities
Reiterated · Market Outperform · 2025-08-12
$21.00
+100.00%
Piper Sandler
Upgraded · Neutral → Overweight · 2025-03-20
$16.00
+52.40%
Northcoast Research
Upgraded · Neutral → Buy · 2024-01-10
—
—
Guggenheim
Reiterated · Buy · 2023-08-09
—
—
Canaccord Genuity
Reiterated · Buy · 2023-05-11
—
—
Truist Securities
Reiterated · Buy · 2022-05-12
—
—
Raymond James
Reiterated · Market Perform → Perform · 2021-04-19
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space